FDA turns to Fre­se­nius im­ports from EU to help with com­mon can­cer drug short­age

The FDA ac­knowl­edged to­day that it’s been al­low­ing tem­po­rary im­ports of the com­mon­ly used can­cer drug cis­platin from Fre­se­nius Kabi to help shore up the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.